Friday, May 1, 2026

North Korea’s New Destroyer Gets Stuck on the Ramp

North Korea's destroyer launch mishap angered Kim Jong Un, leading to investigations and potential delays in military deployment plans.

Seers Technology Partners with PureHealth: A New Era for AI in UAE Healthcare

Seers Technology partners with UAE's PureHealth for AI-based patient monitoring, expanding digital healthcare collaboration and pilot programs.

U.S. Air Force KC-135 Tanker Crash in Iraq: What Went Wrong?

A U.S. Air Force KC-135 tanker crashed in Iraq, marking the first casualties since hostilities with Iran began; rescue operations are ongoing.

Tag: biotechnology

Global AI Driven Rare Disease Diagnostics Firm 3Billion Enters the U.S. Insurance Market

3Billion is expanding globally, entering the U.S. insurance market, enhancing diagnostics, and pursuing drug development for growth.

Discover the Breakthroughs of Korea’s ARPA-H Project at BIO KOREA 2026!

The K-Health Future Promotion Team will unveil interim results of the Korean-style ARPA-H project at BIO KOREA 2026, addressing healthcare challenges.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

How SCL Science’s Digital Logistics Platform BIONECT is Revolutionizing the Cold Chain Industry

SCL Science showcased its next-gen bio-logistics platform at the Korea Cold Chain 2026, emphasizing advanced cold chain logistics for healthcare.

Top 3 Innovative Korean Biotech Firms Shine at Novo Nordisk Partnering Day 2026

Novo Nordisk Korea hosted Partnering Day 2026 to foster global partnerships in healthcare, highlighting innovative local biotech firms.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

AI in Healthcare: How Lunit and KAIST Are Revolutionizing Medical Technology in 2026

South Korea enhances AI in healthcare with Lunit and KAIST's models, achieving high accuracy and speed for medical applications.

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us